Pain News and Research

Latest Pain News and Research

Brachytherapy for lung cancer

A 58-year-old man who lives in Corona, Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not realize it at the time, he had lung cancer. Recently, he made medical history as the first patient in the United States to be treated for lung cancer through the use of radioactive pellets placed directly in the tumor, and today his recovery is going well. Known as brachytherapy, this treatment approach is commonly used to treat prostate cancer.

18 Dec 2009

ISTA Pharmaceuticals files sNDA for bromfenac ophthalmic solution

ISTA Pharmaceuticals, Inc., today announced the Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.

18 Dec 2009

Statistics show China may surpass U.S. in academic output by next decade

Data from a recent Thomson Reuters study show that Chinese research output has increased from just over 20,000 papers in 1998 to nearly 112,000 in 2008.

18 Dec 2009

Adimab announces initiation of research collaborations with two other companies

Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of research collaborations with Pfizer and an undisclosed second company. Adimab also announced the receipt of milestone payments from two recently announced discovery collaborations with Merck and Roche.

17 Dec 2009

Positive results from DURECT's Phase IIb POSIDUR clinical trial for post-surgical pain

DURECT Corporation announced today positive results from a 60 patient Phase IIb clinical trial of POSIDUR(TM), a proprietary product under development for the treatment of post-surgical pain.

17 Dec 2009

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint was achieved in the Company’s Phase 2 pain study assessing the efficacy and safety of BEMA Buprenorphine. The positive results follow BDSI’s March 2009 announcement of favorable Phase 1 study results.

17 Dec 2009

Tips for healthy living for the year ahead

Whether you are a vegetarian, vegan, carnivore or pescetarian, vegetables should be a central part of your diet. Often referred to as a "protective food," dark green foods provide essential vitamins and nutrients to your body that protect you from many of life's worst diseases.

17 Dec 2009

Prophylactic misuse of NSAIDs cause more harm than good

Athletes' superstitions and rituals can help them get psyched up for contests, but when these rituals involve non-steroidal anti-inflammatory drugs (NSAIDs), which many athletes gobble down before and during events, they could be causing more harm than good.

17 Dec 2009

New Tandem fund of $300 million presents financing option for Canada’s biotechnology industry

The new Tandem fund of $300 million announced last week presents a much-needed financing option for Canada’s biotechnology industry. The Fund received investments from the Business Development Bank of Canada (BDC), and Export Development Canada (EDC), contributing $80 and $75 million respectively to the Fund.

17 Dec 2009

RTI Biologics donates spinal allografts to AIC-CURE International Children’s Hospital, Kenya

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, hernia and other biologic implants, donated nearly 500 spinal allografts to AIC-CURE International Children’s Hospital in Kijabe, Kenya this week.

17 Dec 2009

ASA offers practical ways for sufferers to take active role in treatment of pain

Whether the result of injury, illness or a chronic condition, 70 million Americans experience pain annually. The individual pain sufferer may experience a diminished quality of life, lack of mobility and added stress.

17 Dec 2009

Sanofi Pasteur uses PHT’s LogPad System and StudyWorks online portal for its Phase II trial

PHT Corporation announced that Sanofi Pasteur is using PHT’s LogPad® System and StudyWorksTM online portal for a Phase II trial to develop a vaccine against the Clostridium difficile bacterium.

17 Dec 2009

Canadian researchers explore parameters to define and assess chronic pain in infants

A team of Canadian researchers probed 45 pediatric clinicians to learn about possible indicators that could help identify infants with chronic pain and provide guidance on how to differentiate chronic pain from lingering pain caused by medical procedures.

17 Dec 2009

Majority of Canadians confuse sinusitis with H1N1 symptoms

It's winter, that great Canadian season of snow, ice, grey skies...and colds and the flu. In a year when H1N1 is high on everyone's radar, it is more important than ever for Canadians to know what their symptoms mean and when they should see their doctor.

17 Dec 2009

Flowers can uplift patients’ mood and reduce pain and anxiety

Does flower water harbour potentially deadly bacteria? Do bedside blooms compete with patients for oxygen? Do bouquets pose a health and safety risk around medical equipment?

17 Dec 2009

UC San Diego Medical Center performs complex surgery on brain lesion

Over three decades, a world-recognized medical team at UC San Diego Medical Center has spurred the evolution of a complex surgery to destroy dangerous clusters of arteries and veins in the brain. Integrating innovative approaches in radiology, anesthesia, and surgery, the team has perfected a method to systematically starve these abnormal brain lesions, artery by artery, vein by vein.

17 Dec 2009

Top-line efficacy and safety results from Phase 2b clinical trial of XIAFLEX announced

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced top-line efficacy and safety results from a Phase 2b clinical trial of XIAFLEX(TM) for the treatment of Peyronie's disease.

17 Dec 2009

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has signed a three-year single source provider contract with Novation, the industry's leading supply contracting company, for MAQUET's market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems.

16 Dec 2009

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.

16 Dec 2009

Positive results from Auxilium Pharmaceuticals' XIAFLEX Peyronie's disease phase IIb trial

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced top-line efficacy and safety results for the phase IIb clinical trial for XIAFLEX™ (collagenase clostridium histolyticum) in the treatment of Peyronie's disease.

16 Dec 2009

Pain News and Research

Latest Pain News and Research

Brachytherapy for lung cancer

ISTA Pharmaceuticals files sNDA for bromfenac ophthalmic solution

Statistics show China may surpass U.S. in academic output by next decade

Adimab announces initiation of research collaborations with two other companies

Positive results from DURECT's Phase IIb POSIDUR clinical trial for post-surgical pain

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

Tips for healthy living for the year ahead

Prophylactic misuse of NSAIDs cause more harm than good

New Tandem fund of $300 million presents financing option for Canada’s biotechnology industry

RTI Biologics donates spinal allografts to AIC-CURE International Children’s Hospital, Kenya

ASA offers practical ways for sufferers to take active role in treatment of pain

Sanofi Pasteur uses PHT’s LogPad System and StudyWorks online portal for its Phase II trial

Canadian researchers explore parameters to define and assess chronic pain in infants

Majority of Canadians confuse sinusitis with H1N1 symptoms

Flowers can uplift patients’ mood and reduce pain and anxiety

UC San Diego Medical Center performs complex surgery on brain lesion

Top-line efficacy and safety results from Phase 2b clinical trial of XIAFLEX announced

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Positive results from Auxilium Pharmaceuticals' XIAFLEX Peyronie's disease phase IIb trial

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Pain News and Research

Latest Pain News and Research

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in